This NDC is on FDA's drug shortage list (posted Mar 26, 2018)

Reported reason: Other

Product Information

KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.4980 per ML under NDC 00409379601. Its NADAC has been published 634 times since Nov 28, 2013.

FDA first approved this application on Jun 5, 1997. Its Orange Book therapeutic-equivalence code is AP.

KETOROLAC 60 MG/2 ML VIAL

KETOROLAC TROMETHAMINE
$0.4980per ML

Strength

60 mg/2mL

Manufacturer

Hospira Inc.

NDC

00409379601

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR

Effective Date

8/19/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA074802

FDA Approved

6/5/1997

TE Code

AP

On Market Since

10/30/2015

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 634 times since Nov 28, 2013, and over the history we have for it it has risen 21.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4980 per ML
All-time high$1.5377 (Apr 15, 2015)
All-time low$0.3997 (Feb 19, 2014)
52-week high$0.5738
52-week low$0.4543
Median price$0.8975
Average price$0.8929
Largest weekly change+94.1% (Mar 18, 2015)
Weeks tracked634
Tracking sinceNov 28, 2013

Price History

1W

+3.7%

1M

+3.7%

3M

-3.1%

6M

+9.6%

1Y

-13.1%

3Y

-37.8%

5Y

-44.5%

All

+21.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Hospira Inc., is $0.4980 per ML (NDC 00409379601), effective Aug 19, 2026.

How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has risen 21.6%. It has been tracked across 634 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?

Since Nov 28, 2013, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.3997 (Feb 19, 2014) to a high of $1.5377 (Apr 15, 2015), with a median of $0.8975 per ML.

Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 60 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures KETOROLAC 60 MG/2 ML VIAL?

KETOROLAC 60 MG/2 ML VIAL (NDC 00409379601) is labeled by Hospira Inc., and CMS classifies it as a generic product.

Is KETOROLAC 60 MG/2 ML VIAL in shortage?

Yes — NDC 00409379601 is currently listed in FDA's drug shortage database (posted Mar 26, 2018). Reported reason: Other.